India’s Diabetes Economic Burden: $10 Billion Annual Cost vs. $21.7 Billion Market Growth by 2030
Diabetes imposes a heavy economic burden on India, with annual costs exceeding $10 billion—equivalent to 1.5% of the country’s GDP. This includes direct medical expenses (drugs, devices, hospitalizations) and indirect costs (lost productivity, reduced workforce participation). Yet, despite this strain, the India diabetes market is thriving, projected to reach $21.7 billion by 2030....
0 Commentaires
0 Parts
888 Vue
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt